» Articles » PMID: 11032864

Differential Coreceptor Expression Allows for Independent Evolution of Non-syncytium-inducing and Syncytium-inducing HIV-1

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2000 Oct 18
PMID 11032864
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

We demonstrated previously that CD45RA(+) CD4(+) T cells are infected primarily by syncytium-inducing (SI) HIV-1 variants, whereas CD45RO(+) CD4(+) T cells harbor both non-SI (NSI) and SI HIV-1 variants. Here, we studied evolution of tropism for CD45RA(+) and CD45RO(+) CD4(+) cells, coreceptor usage, and molecular phylogeny of coexisting NSI and SI HIV-1 clones that were isolated from four patients in the period spanning SI conversion. NSI variants were CCR5-restricted and could be isolated throughout infection from CD45RO(+) CD4(+) cells. SI variants seemed to evolve in CD45RO(+) CD4(+) cells, but, in time, SI HIV-1 infection of CD45RA(+) CD4(+) cells equaled infection of CD45RO(+) CD4(+) cells. In parallel with this shift, SI HIV-1 variants first used both coreceptors CCR5 and CXCR4, but eventually lost the ability to use CCR5. Phylogenetically, NSI and SI HIV-1 populations diverged over time. We observed a differential expression of HIV-1 coreceptors within CD45RA(+) and CD45RO(+) cells, which allowed us to isolate virus from purified CCR5(+) CXCR4(-) and CCR5(-) CXCR4(+) CD4(+) cells. The CCR5(+) subset was exclusively infected by CCR5-dependent HIV-1 clones, whereas SI clones were preferentially isolated from the CXCR4(+) subset. The differential expression of HIV-1 coreceptors provides distinct cellular niches for NSI and SI HIV-1, contributing to their coexistence and independent evolutionary pathways.

Citing Articles

CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair.

Jasinska A, Pandrea I, Apetrei C Front Immunol. 2022; 13:835994.

PMID: 35154162 PMC: 8829453. DOI: 10.3389/fimmu.2022.835994.


Host and Viral Factors in HIV-Mediated Bystander Apoptosis.

Garg H, Joshi A Viruses. 2017; 9(8).

PMID: 28829402 PMC: 5579491. DOI: 10.3390/v9080237.


Daily sampling of an HIV-1 patient with slowly progressing disease displays persistence of multiple env subpopulations consistent with neutrality.

Skar H, Gutenkunst R, Ramsay K, Alaeus A, Albert J, Leitner T PLoS One. 2011; 6(8):e21747.

PMID: 21829600 PMC: 3149046. DOI: 10.1371/journal.pone.0021747.


Efficiency of CCR5 coreceptor utilization by the HIV quasispecies increases over time, but is not associated with disease progression.

Redd A, Laeyendecker O, Kong X, Kiwanuka N, Lutalo T, Huang W AIDS Res Hum Retroviruses. 2011; 28(3):289-94.

PMID: 21663455 PMC: 3292754. DOI: 10.1089/AID.2011.0006.


Evolution of human immunodeficiency virus type 1 in a patient with cross-reactive neutralizing activity in serum.

van Gils M, Edo-Matas D, Bowles E, Burger J, Stewart-Jones G, Schuitemaker H J Virol. 2011; 85(16):8443-8.

PMID: 21653664 PMC: 3147988. DOI: 10.1128/JVI.05214-11.


References
1.
de Roda Husman A, van Rij R, Blaak H, Broersen S, Schuitemaker H . Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression. J Infect Dis. 1999; 180(4):1106-15. DOI: 10.1086/314987. View

2.
Schramm B, Penn M, Speck R, Chan S, De Clercq E, Schols D . Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease. J Virol. 1999; 74(1):184-92. PMC: 111527. DOI: 10.1128/jvi.74.1.184-192.2000. View

3.
Hazenberg M, Stuart J, Otto S, Borleffs J, Boucher C, de Boer R . T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood. 1999; 95(1):249-55. View

4.
Moulard M, Lortat-Jacob H, Mondor I, Roca G, Wyatt R, Sodroski J . Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J Virol. 2000; 74(4):1948-60. PMC: 111673. DOI: 10.1128/jvi.74.4.1948-1960.2000. View

5.
Kwong P, Wyatt R, Sattentau Q, Sodroski J, Hendrickson W . Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus. J Virol. 2000; 74(4):1961-72. PMC: 111674. DOI: 10.1128/jvi.74.4.1961-1972.2000. View